ViaDerma, Inc.
VDRM
$0.018
$0.00021.12%
| 09/30/2017 | |||||
|---|---|---|---|---|---|
| Revenue | -91.62% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -91.62% | ||||
| Cost of Revenue | -76.67% | ||||
| Gross Profit | -92.77% | ||||
| SG&A Expenses | 134.87% | ||||
| Depreciation & Amortization | 0.00% | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 114.99% | ||||
| Operating Income | -802.66% | ||||
| Income Before Tax | -486.69% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -486.69% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -486.69% | ||||
| EBIT | -802.66% | ||||
| EBITDA | -793.68% | ||||
| EPS Basic | -150.00% | ||||
| Normalized Basic EPS | -200.00% | ||||
| EPS Diluted | -150.00% | ||||
| Normalized Diluted EPS | -200.00% | ||||
| Average Basic Shares Outstanding | 122.95% | ||||
| Average Diluted Shares Outstanding | 122.95% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||
